A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies
Paula M. Fracasso, Sherry A. Goodner, Jonathan D. Wildi, Michael J. Naughton, Gerald P. Linette, Ramaswamy Govindan, Benjamin R. Tan, Kristie A. Blum, Gary J. Jones, Tillman E. Pearce, Daniel J. Levitt, Gerald H. Clamon
Dive into the research topics of 'A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies'. Together they form a unique fingerprint.